267 related articles for article (PubMed ID: 38173014)
41. Microglial amyloid beta clearance is driven by PIEZO1 channels.
Jäntti H; Sitnikova V; Ishchenko Y; Shakirzyanova A; Giudice L; Ugidos IF; Gómez-Budia M; Korvenlaita N; Ohtonen S; Belaya I; Fazaludeen F; Mikhailov N; Gotkiewicz M; Ketola K; Lehtonen Š; Koistinaho J; Kanninen KM; Hernández D; Pébay A; Giugno R; Korhonen P; Giniatullin R; Malm T
J Neuroinflammation; 2022 Jun; 19(1):147. PubMed ID: 35706029
[TBL] [Abstract][Full Text] [Related]
42. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease.
Streit WJ; Braak H; Xue QS; Bechmann I
Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731
[TBL] [Abstract][Full Text] [Related]
43. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
Hickman SE; Allison EK; El Khoury J
J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
[TBL] [Abstract][Full Text] [Related]
44. Microglial Piezo1 senses Aβ fibril stiffness to restrict Alzheimer's disease.
Hu J; Chen Q; Zhu H; Hou L; Liu W; Yang Q; Shen H; Chai G; Zhang B; Chen S; Cai Z; Wu C; Hong F; Li H; Chen S; Xiao N; Wang ZX; Zhang X; Wang B; Zhang L; Mo W
Neuron; 2023 Jan; 111(1):15-29.e8. PubMed ID: 36368316
[TBL] [Abstract][Full Text] [Related]
45. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
46. Aβ42 Protofibrils Interact with and Are Trafficked through Microglial-Derived Microvesicles.
Gouwens LK; Ismail MS; Rogers VA; Zeller NT; Garrad EC; Amtashar FS; Makoni NJ; Osborn DC; Nichols MR
ACS Chem Neurosci; 2018 Jun; 9(6):1416-1425. PubMed ID: 29543435
[TBL] [Abstract][Full Text] [Related]
47. APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease.
Manocha GD; Floden AM; Rausch K; Kulas JA; McGregor BA; Rojanathammanee L; Puig KR; Puig KL; Karki S; Nichols MR; Darland DC; Porter JE; Combs CK
J Neurosci; 2016 Aug; 36(32):8471-86. PubMed ID: 27511018
[TBL] [Abstract][Full Text] [Related]
48. CSB6B prevents β-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-κB and NLRP3 in microglia cells.
Yan S; Xuan Z; Yang M; Wang C; Tao T; Wang Q; Cui W
Int Immunopharmacol; 2020 Apr; 81():106263. PubMed ID: 32028243
[TBL] [Abstract][Full Text] [Related]
49. Mild magnetic nanoparticle hyperthermia promotes the disaggregation and microglia-mediated clearance of beta-amyloid plaques.
Dyne E; Prakash PS; Li J; Yu B; Schmidt TL; Huang S; Kim MH
Nanomedicine; 2021 Jun; 34():102397. PubMed ID: 33857686
[TBL] [Abstract][Full Text] [Related]
50. An "Amyloid-β Cleaner" for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction.
Liu R; Yang J; Liu L; Lu Z; Shi Z; Ji W; Shen J; Zhang X
Adv Sci (Weinh); 2020 Jan; 7(2):1901555. PubMed ID: 31993283
[TBL] [Abstract][Full Text] [Related]
51. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.
Xia D; Lianoglou S; Sandmann T; Calvert M; Suh JH; Thomsen E; Dugas J; Pizzo ME; DeVos SL; Earr TK; Lin CC; Davis S; Ha C; Leung AW; Nguyen H; Chau R; Yulyaningsih E; Lopez I; Solanoy H; Masoud ST; Liang CC; Lin K; Astarita G; Khoury N; Zuchero JY; Thorne RG; Shen K; Miller S; Palop JJ; Garceau D; Sasner M; Whitesell JD; Harris JA; Hummel S; Gnörich J; Wind K; Kunze L; Zatcepin A; Brendel M; Willem M; Haass C; Barnett D; Zimmer TS; Orr AG; Scearce-Levie K; Lewcock JW; Di Paolo G; Sanchez PE
Mol Neurodegener; 2022 Jun; 17(1):41. PubMed ID: 35690868
[TBL] [Abstract][Full Text] [Related]
52. Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.
Boza-Serrano A; Ruiz R; Sanchez-Varo R; García-Revilla J; Yang Y; Jimenez-Ferrer I; Paulus A; Wennström M; Vilalta A; Allendorf D; Davila JC; Stegmayr J; Jiménez S; Roca-Ceballos MA; Navarro-Garrido V; Swanberg M; Hsieh CL; Real LM; Englund E; Linse S; Leffler H; Nilsson UJ; Brown GC; Gutierrez A; Vitorica J; Venero JL; Deierborg T
Acta Neuropathol; 2019 Aug; 138(2):251-273. PubMed ID: 31006066
[TBL] [Abstract][Full Text] [Related]
53. Determining the role of IL-4 induced neuroinflammation in microglial activity and amyloid-β using BV2 microglial cells and APP/PS1 transgenic mice.
Latta CH; Sudduth TL; Weekman EM; Brothers HM; Abner EL; Popa GJ; Mendenhall MD; Gonzalez-Oregon F; Braun K; Wilcock DM
J Neuroinflammation; 2015 Mar; 12():41. PubMed ID: 25885682
[TBL] [Abstract][Full Text] [Related]
54. Novel molecular mechanism driving neuroprotection after soluble epoxide hydrolase inhibition: Insights for Alzheimer's disease therapeutics.
Griñán-Ferré C; Jarné-Ferrer J; Bellver-Sanchís A; Codony S; Puigoriol-Illamola D; Sanfeliu C; Oh Y; Lee S; Vázquez S; Pallàs M
CNS Neurosci Ther; 2024 Apr; 30(4):e14511. PubMed ID: 37905690
[TBL] [Abstract][Full Text] [Related]
55. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
56. The development of preventives and therapeutics for Alzheimer's disease that inhibit the formation of beta-amyloid fibrils (fAbeta), as well as destabilize preformed fAbeta.
Ono K; Naiki H; Yamada M
Curr Pharm Des; 2006; 12(33):4357-75. PubMed ID: 17105432
[TBL] [Abstract][Full Text] [Related]
57. Early-life stress lastingly alters the neuroinflammatory response to amyloid pathology in an Alzheimer's disease mouse model.
Hoeijmakers L; Ruigrok SR; Amelianchik A; Ivan D; van Dam AM; Lucassen PJ; Korosi A
Brain Behav Immun; 2017 Jul; 63():160-175. PubMed ID: 28027926
[TBL] [Abstract][Full Text] [Related]
58. Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway.
Yang R; Liu S; Zhou J; Bu S; Zhang J
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):276-284. PubMed ID: 28669260
[TBL] [Abstract][Full Text] [Related]
59. Nucleotides released from Aβ₁₋₄₂ -treated microglial cells increase cell migration and Aβ₁₋₄₂ uptake through P2Y₂ receptor activation.
Kim HJ; Ajit D; Peterson TS; Wang Y; Camden JM; Gibson Wood W; Sun GY; Erb L; Petris M; Weisman GA
J Neurochem; 2012 Apr; 121(2):228-38. PubMed ID: 22353164
[TBL] [Abstract][Full Text] [Related]
60. The extracts of Dracaena cochinchinensis stemwood suppress inflammatory response and phagocytosis in lipopolysaccharide-activated microglial cells.
Ospondpant D; Xia Y; Lai QWS; Yuen GK; Yang M; Chanthanam K; Dong TT; Tsim KWK
Phytomedicine; 2023 Sep; 118():154936. PubMed ID: 37385071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]